Intensive healing protocol More aggressive stacking approaches employ higher doses and more frequent administration for acute or severe injuries requiring rapid intervention
3 Biotech 16 , 312 (2026)
Each production batch undergoes comprehensive analytical validation, including High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and UV spectrophotometry, ensuring precise molecular identity, high purity, and batch-to-batch consistency
Peptide origin / Partial sequence of human gastric protein BPC, isolated from gastric juice Molecular weight / Approximately 1,419 Da (15 amino acids) Common off-label oral dose / 250 to 500 mcg twice daily, taken on an empty stomach Common off-label subcutaneous dose / 200 to 300 mcg once or twice daily near the affected area or abdominally Evidence level / Preclinical only (GRADE: very low certainty for human GI healing) Key preclinical finding / Accelerated gastric ulcer healing in rats within 24 to 72 hours across multiple models Route preference for GI targets / Oral administration, based on topical mucosal contact rationale Safety profile in humans / Largely unknown
MT-II nasal spray formulations have been studied for comparative bioavailability relative to subcutaneous delivery contributing to the broader field of non-invasive peptide administration research
